Transcatheter heart valves technologies

Concomitant aortic regurgitation predicts better left ventricular reverse remodeling after transcatheter aortic valve replacement

Published on 20/07/2023 | Yang Hao-Ran et al. | BMC Cardiovascular Disorders 2023; 23(1): 354 | 16 minute read

Abstract Background We aim to determine predictors of inadequate left ventricular mass index (LVMi) regression at mid-term after transcatheter aortic

Transcatheter heart valves technologies

Percutaneous treatment of abdominal aortic aneurysm and aortic valve stenosis with ‘staged’ EVAR and TAVR: a case series

Published on 20/07/2023 | Medda Massimo 1 et al. | Journal of Cardiothoracic Surgery 2023; 18(1): 230 | 30 minute read

Abstract Symptomatic aortic valve stenosis (AS) and abdominal aortic aneurysm (AAA) are critical clinical conditions, increasingly more prevalent with aging

Transcatheter heart valves technologies

Is the outcome of elective vs non-elective patients undergoing transcatheter aortic valve implantation different? Results of a single-centre, observational assessment of outcomes at a large university clinic

Published on 06/07/2023 | Wundram Steffen 1 et al. | BMC Cardiovascular Disorders 2023; 23(1): 295 | 23 minute read

Abstract Background Transcatheter aortic valve implantation (TAVI) can either be conducted as an elective (scheduled in advance) or a non-elective

Transcatheter heart valves technologies

Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta‐analysis

Published on 15/06/2023 | Irbaz HameedMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30674 | 17 minute read

Abstract Background Post‐procedural aortic insufficiency (AI) continues to be prevalent following transcatheter aortic valve replacement (TAVR). While several studies have

Transcatheter heart valves technologies

The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions

Published on 15/06/2023 | Pooja S. YesantharaoMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30670 | 21 minute read

Abstract Background Transcatheter aortic valve replacement (TAVR) is an increasingly used but relatively expensive procedure with substantial associated readmission rates.

Transcatheter heart valves technologies

Optimization of Preprocedural Full-cycle Computed Tomography in Patients Referred for Transcatheter Tricuspid Valve Repair: Test Bolus Versus Bolus Tracking

Published on 01/06/2023 | Escher et al. | Journal of Thoracic Imaging 2023; 38(3): 174-8 | 13 minute read

Abstract Purpose/objectives Advancements in transcatheter mitral and tricuspid valve repair have resulted in growing demands in preprocedural computed tomography (CT)

Transcatheter heart valves technologies

Multi-modality imaging for pre-procedural planning of transcatheter mitral valve interventions

Published on 18/05/2023 | Pierpaolo Tarzia et al. | European Heart Journal Supplement 2023; 25(Supplement_C): C205 | 18 minute read

Abstract Transcatheter mitral valve interventions (TMVI), either repair or replacement, are established alternative options for patients with mitral regurgitation (MR)

Transcatheter heart valves technologies

Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation

Published on 18/05/2023 | Jose M. De la Torre HernandezMD et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30673 | 16 minute read

Abstract Objectives We sought to investigate the effect of a 15‐min delayed intraprocedural reassessment of paravalvular aortic regurgitation (PVR) after

Transcatheter heart valves technologies

Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies

Published on 04/05/2023 | Michel Pompeu SáMD et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30666 | 22 minute read

Abstract Background Permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is associated with higher risk of mortality and

Transcatheter heart valves technologies

Noninvasive Hemodynamic Evaluation Following TAVI for Severe Aortic Stenosis

Published on 20/04/2023 | TzlilGrinbergMD 1 et al. | Journal of the American Heart Association 2023; 12(7): 028479 | 22 minute read

Abstract Background Various hemodynamic changes occur following transcatheter aortic valve implantation (TAVI) that may impact therapeutic decisions. NICaS is a

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.